Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review.

ABSTRACT:

Background

Digital adherence technologies (DATs) may provide a patient-centred approach to supporting tuberculosis (TB) medication adherence and improving treatment outcomes. We synthesised evidence addressing costs and cost-effectiveness of DATs to support TB treatment.

Methods

A systematic review (PROSPERO-CRD42022313531) identified relevant literature from January 2000 to April 2023 in MEDLINE, Embase, CENTRAL, CINAHL, Web of Science along with preprints from medRxiv, Europe PMC and ClinicalTrials.gov. Studies with observational, experimental or quasi-experimental designs (minimum 20 participants) and modelling studies reporting quantitative data on the cost or cost-effectiveness of DATs for TB infection or disease treatment were included. Study characteristics, cost and

SUBMITTER: Kafie C 

PROVIDER: S-EPMC11529515 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature